Visser SA

ORCID: 0009-0008-2186-7195 · 2 papers in corpus
2016
CPT: pharmacometrics & systems pharmacology ·doi:10.1002/psp4.12049

This document was developed to enable greater consistency in the practice, application, and documentation of Model-Informed Drug Discovery and Development (MID3) across the pharmaceutical industry. A collection of "good practice" recommenda…

2014
CPT: pharmacometrics & systems pharmacology ·doi:10.1038/psp.2014.40

Quantitative and systems pharmacology concepts and tools are the foundation of the model-informed drug development paradigm at Merck for integrating knowledge, enabling decisions, and enhancing submissions. Rigorous prioritization of modeli…